-
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Average Rating of "Moderate Buy" by Brokerages
Source: Buzz FX / 03 Mar 2025 05:12:13 America/New_York
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Average Rating of "Moderate Buy" by Brokerages Written by MarketBeat March 3, 2025 Share Link copied to clipboard. Esperion Therapeutics, Inc. ( NASDAQ:ESPR - Get Free Report ) has received a
Read more...